https://news.mit.edu/2023/new-nanoparticles-can-perform-gene-editing-lungs-0330 Skip to content | Massachusetts Institute of Technology MIT Top Menu| * Education * Research * Innovation * Admissions + Aid * Campus Life * News * Alumni * About MIT * More | Search MIT Search websites, locations, and people [ ] See More Results Suggestions or feedback? MIT News | Massachusetts Institute of Technology Subscribe to MIT News newsletter Browse Enter keywords to search for news articles: [ ] Submit Browse By Topics View All - Explore: * Machine learning * Social justice * Startups * Black holes * Classes and programs Departments View All - Explore: * Aeronautics and Astronautics * Brain and Cognitive Sciences * Architecture * Political Science * Mechanical Engineering Centers, Labs, & Programs View All - Explore: * Abdul Latif Jameel Poverty Action Lab (J-PAL) * Picower Institute for Learning and Memory * Media Lab * Lincoln Laboratory Schools * School of Architecture + Planning * School of Engineering * School of Humanities, Arts, and Social Sciences * Sloan School of Management * School of Science * MIT Schwarzman College of Computing View all news coverage of MIT in the media - Listen to audio content from MIT News - Subscribe to MIT newsletter - Close Breadcrumb 1. MIT News 2. New nanoparticles can perform gene editing in the lungs New nanoparticles can perform gene editing in the lungs Using these RNA-delivery particles, researchers hope to develop new treatments for cystic fibrosis and other lung diseases. Anne Trafton | MIT News Office Publication Date: March 30, 2023 Press Inquiries Press Contact: Sarah McDonnell Email: s_mcd@mit.edu Phone: 617-253-8923 Fax: 617-258-8762 MIT News Office Media Download Rendering of a translucent person shows glowing orange pathways inside of lungs. Some glowing green 'nanoparticle' dots appear inside the pathways. | Download Image Caption: Engineers at MIT and the University of Massachusetts Medical School have designed a new type of nanoparticle that can be administered to the lungs, where it can deliver messenger RNA encoding useful proteins. Credits: Image: iStock, edited by MIT News *Terms of Use: Images for download on the MIT News office website are made available to non-commercial entities, press and the general public under a Creative Commons Attribution Non-Commercial No Derivatives license. You may not alter the images provided, other than to crop them to size. A credit line must be used when reproducing images; if one is not provided below, credit the images to "MIT." Close Rendering of a translucent person shows glowing orange pathways inside of lungs. Some glowing green 'nanoparticle' dots appear inside the pathways. Caption: Engineers at MIT and the University of Massachusetts Medical School have designed a new type of nanoparticle that can be administered to the lungs, where it can deliver messenger RNA encoding useful proteins. Credits: Image: iStock, edited by MIT News Previous image Next image Engineers at MIT and the University of Massachusetts Medical School have designed a new type of nanoparticle that can be administered to the lungs, where it can deliver messenger RNA encoding useful proteins. With further development, these particles could offer an inhalable treatment for cystic fibrosis and other diseases of the lung, the researchers say. "This is the first demonstration of highly efficient delivery of RNA to the lungs in mice. We are hopeful that it can be used to treat or repair a range of genetic diseases, including cystic fibrosis," says Daniel Anderson, a professor in MIT's Department of Chemical Engineering and a member of MIT's Koch Institute for Integrative Cancer Research and Institute for Medical Engineering and Science (IMES). In a study of mice, Anderson and his colleagues used the particles to deliver mRNA encoding the machinery needed for CRISPR/Cas9 gene editing. That could open the door to designing therapeutic nanoparticles that can snip out and replace disease-causing genes. The senior authors of the study, which appears today in Nature Biotechnology, are Anderson; Robert Langer, the David H. Koch Institute Professor at MIT; and Wen Xue, an associate professor at the UMass Medical School RNA Therapeutics Institute. Bowen Li, a former MIT postdoc who is now an assistant professor at the University of Toronto; Rajith Singh Manan, an MIT postdoc; and Shun-Qing Liang, a postdoc at UMass Medical School, are paper's lead authors. Targeting the lungs Messenger RNA holds great potential as a therapeutic for treating a variety of diseases caused by faulty genes. One obstacle to its deployment thus far has been difficulty in delivering it to the right part of the body, without off-target effects. Injected nanoparticles often accumulate in the liver, so several clinical trials evaluating potential mRNA treatments for diseases of the liver are now underway. RNA-based Covid-19 vaccines, which are injected directly into muscle tissue, have also proven effective. In many of those cases, mRNA is encapsulated in a lipid nanoparticle -- a fatty sphere that protects mRNA from being broken down prematurely and helps it enter target cells. Several years ago, Anderson's lab set out to design particles that would be better able to transfect the epithelial cells that make up most of the lining of the lungs. In 2019, his lab created nanoparticles that could deliver mRNA encoding a bioluminescent protein to lung cells. Those particles were made from polymers instead of lipids, which made them easier to aerosolize for inhalation into the lungs. However, more work is needed on those particles to increase their potency and maximize their usefulness. In their new study, the researchers set out to develop lipid nanoparticles that could target the lungs. The particles are made up of molecules that contain two parts: a positively charged headgroup and a long lipid tail. The positive charge of the headgroup helps the particles to interact with negatively charged mRNA, and it also help mRNA to escape from the cellular structures that engulf the particles once they enter cells. The lipid tail structure, meanwhile, helps the particles to pass through the cell membrane. The researchers came up with 10 different chemical structures for the lipid tails, along with 72 different headgroups. By screening different combinations of these structures in mice, the researchers were able to identify those that were most likely to reach the lungs. Efficient delivery In further tests in mice, the researchers showed that they could use the particles to deliver mRNA encoding CRISPR/Cas9 components designed to cut out a stop signal that was genetically encoded into the animals' lung cells. When that stop signal is removed, a gene for a fluorescent protein turns on. Measuring this fluorescent signal allows the researchers to determine what percentage of the cells successfully expressed the mRNA. After one dose of mRNA, about 40 percent of lung epithelial cells were transfected, the researchers found. Two doses brought the level to more than 50 percent, and three doses up to 60 percent. The most important targets for treating lung disease are two types of epithelial cells called club cells and ciliated cells, and each of these was transfected at about 15 percent. "This means that the cells we were able to edit are really the cells of interest for lung disease," Li says. "This lipid can enable us to deliver mRNA to the lung much more efficiently than any other delivery system that has been reported so far." The new particles also break down quickly, allowing them to be cleared from the lung within a few days and reducing the risk of inflammation. The particles could also be delivered multiple times to the same patient if repeat doses are needed. This gives them an advantage over another approach to delivering mRNA, which uses a modified version of harmless adenoviruses. Those viruses are very effective at delivering RNA but can't be given repeatedly because they induce an immune response in the host. "This achievement paves the way for promising therapeutic lung gene delivery applications for various lung diseases," says Dan Peer, director of the Laboratory of Precision NanoMedicine at Tel Aviv University, who was not involved in the study. "This platform holds several advantages compared to conventional vaccines and therapies, including that it's cell-free, enables rapid manufacturing, and has high versatility and a favorable safety profile." To deliver the particles in this study, the researchers used a method called intratracheal instillation, which is often used as a way to model delivery of medication to the lungs. They are now working on making their nanoparticles more stable, so they could be aerosolized and inhaled using a nebulizer. The researchers also plan to test the particles to deliver mRNA that could correct the genetic mutation found in the gene that causes cystic fibrosis, in a mouse model of the disease. They also hope to develop treatments for other lung diseases, such as idiopathic pulmonary fibrosis, as well as mRNA vaccines that could be delivered directly to the lungs. The research was funded by Translate Bio, the National Institutes of Health, the Leslie Dan Faculty of Pharmacy startup fund, a PRiME Postdoctoral Fellowship from the University of Toronto, the American Cancer Society, and the Cystic Fibrosis Foundation. Share this news article on: * Twitter * Facebook * LinkedIn * Reddit * Print Related Links * Daniel Anderson * Koch Institute * Department of Chemical Engineering * Institute for Medical Engineering and Science * School of Engineering Related Topics * Research * Chemical engineering * RNA * CRISPR * Genetics * Nanoscience and nanotechnology * Drug development * Medicine * Koch Institute * Institute for Medical Engineering and Science (IMES) * School of Engineering * National Institutes of Health (NIH) Related Articles MIT researchers have designed inhalable particles that can deliver messenger RNA. These lung epithelial cells have taken up particles (yellow) that carry mRNA encoding green fluorescent protein. Engineers create an inhalable form of messenger RNA MIT researchers have designed nanoparticles that can deliver messenger RNA to specific organs. In this image, lung cells expressing the synthetic mRNA show up as red. New materials improve delivery of therapeutic messenger RNA In a new study, MIT researchers have developed nanoparticles that can deliver the CRISPR genome-editing system and specifically modify genes, eliminating the need to use viruses for delivery. CRISPR-carrying nanoparticles edit the genome A team of researchers from MIT, Georgia Tech, and the University of Florida has devised a way to rapidly test different nanoparticles to see where they go in the body. Nanoparticle screen could speed up drug development Previous item Next item More MIT News Asegun Henry poses in a lab before a large spherical metallic machine Asegun Henry wins National Science Foundation's Alan T. Waterman Award Mechanical engineering associate professor receives the NSF's highest honor for an outstanding early-career scientist or engineer. Read full story - Against a dark background and in colorful, vivid light, about 200 worms are in ball. They are somewhat transparent. How to untangle a worm ball: Mathematicians solve a knotty mystery California blackworms tangle themselves up by the thousands, then separate in a split second. Their trick may inspire the design of self-detangling materials and fibers. Read full story - Jiadi Zhu wears gloves while holding an octagon-shaped plastic case containing 8-inch wafer. On right, a furnace resembling a deep freezer sits in glass casing. MIT engineers "grow" atomically thin transistors on top of computer chips A new low-temperature growth and fabrication technology allows the integration of 2D materials directly onto a silicon circuit, which could lead to denser and more powerful chips. Read full story - Robert Armstrong grips a lecturn with the MITEI logo, with projector screen behind him. Robert Armstrong: A lifetime at the forefront of chemical engineering research and education The longtime professor and current MIT Energy Initiative director is set to retire after 50 years on the MIT faculty. Read full story - Elijah Stanger-Jones, Hongmin Kim, and Andrew SaLoutos look at a metal robot gripper that resembles an excavator. The gripper holds a pink cup as it sits atop a wooden table. Speedy robo-gripper reflexively organizes cluttered spaces Rather than start from scratch after a failed attempt, the pick-and-place robot adapts in the moment to get a better hold. Read full story - Scene of tea farm in Kenya and a farmer with wicker basket. Tea shed, people, shade trees and hills are in the distance. Study offers a new view of when and how governments distribute land In Kenya, property rights are granted more often by democratic regimes than by autocrats -- but decisions tend to be politically motivated regardless of who's in charge. Read full story - * More news on MIT News homepage - More about MIT News at Massachusetts Institute of Technology This website is managed by the MIT News Office, part of the Institute Office of Communications. News by Schools/College: * School of Architecture and Planning * School of Engineering * School of Humanities, Arts, and Social Sciences * MIT Sloan School of Management * School of Science * MIT Schwarzman College of Computing Resources: * About the MIT News Office * MIT News Press Center * Terms of Use * Press Inquiries * Filming Guidelines * RSS Feeds Tools: * Subscribe to MIT Daily/Weekly * Subscribe to press releases * Submit campus news * Guidelines for campus news contributors Massachusetts Institute of Technology MIT Top Level Links: * Education * Research * Innovation * Admissions + Aid * Campus Life * News * Alumni * About MIT * Join us in building a better world. Massachusetts Institute of Technology 77 Massachusetts Avenue, Cambridge, MA, USA Recommended Links: * Visit * Map (opens in new window) * Events (opens in new window) * People (opens in new window) * Careers (opens in new window) * Contact * Privacy * Accessibility * + Social Media Hub + MIT on Twitter + MIT on Facebook + MIT on YouTube + MIT on Instagram